COHN
Cohen & Company Inc.
COHN's fundamentals are strong, but it looks expensive: trading at 4.2x earnings, above its usual 2.4x.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
COHN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
COHN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like COHN.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
COHN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1.2x | $2.61 | -73% |
| Fair | 2.4x | $5.37 | -44% |
| Expensive | 3.3x | $7.52 | -21% |
| Current | 4.2x | $9.52 | — |
Historical ranges are pointers, not guarantees.
COHN's PE is in its expensive range at 4.2x.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
COHN Forward outlook
There aren't enough analyst estimates for COHN to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
COHN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | $4.13 | +$12.32 |
| Q2 2024 | $2.54 | +$11.09 |
| Q1 2024 | -$0.33 | +$5.41 |
| Q4 2023 | -$3.38 | +$6.05 |
COHN has the stronger earnings trend. Trailing diluted EPS is down 46% for COHN versus IREN down 347%.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
COHN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.4M | -61% |
| Q2 2026 | $69.5M | +16% |
| Q1 2026 | $57.9M | +101% |
| Q4 2025 | $102.7M | +454% |
| Q3 2025 | $84.2M | +166% |
| Q2 2025 | $59.9M | +454% |
| Q1 2025 | $28.7M | +55% |
| Q4 2024 | $18.5M | -46% |
COHN's revenue is growing: $32M last quarter, down 61% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.1% | -18 points |
| Q2 2026 | 18% | +5.3 points |
| Q1 2026 | 8.9% | +8.5 points |
| Q4 2025 | 29% | +59 points |
| Q3 2025 | 26% | +3.1 points |
| Q2 2025 | 13% | +72 points |
| Q1 2025 | 0.4% | +19 points |
| Q4 2024 | -30% | -63 points |
COHN has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
COHN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $27.5M | +24% |
| Q2 2026 | $3.7M | -71% |
| Q1 2026 | -$31.5M | -$25M |
| Q4 2025 | -$2.5M | -163% |
| Q3 2025 | $22.2M | +484% |
| Q2 2025 | $12.9M | +$17.5M |
| Q1 2025 | -$6.5M | -230% |
| Q4 2024 | $4M | +$7.5M |
COHN has the edge over IREN on cash flow, with more consistent year-over-year improvement.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
COHN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.3% | +145K shares |
| 1 year | +8.1% | +479K shares |
| 3 years | +347% | +5M shares |
| 5 years | +62% | +2.5M shares |
COHN has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $1,000 |
| Q3 2021 | $187,000 |
| Q2 2021 | $7,000 |
| Q1 2021 | $662,000 |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
COHN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | 0.7x | Very low |
| Q3 2024 | 2.2x | Moderate |
| Q1 2024 | 1.6x | Healthy |
COHN has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like COHN.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
COHN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.4 | Neutral |
| Stochastic | 16.4 | Oversold |
COHN's weekly RSI is 40 (neutral) and its Stochastic is 16 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
COHN PE vs Financial Services Sector
| Metric | COHN | Sector median | Relative |
|---|---|---|---|
| PE | 4.2x | 13x | 68% below |
| PE % | 95 | 63 | 32 pts above |
COHN is trading at 4.2x earnings, a 68% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
COHN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.95 | 4.3% below |
| 20 week MA | $11.3 | 16% below |
| 50 week MA | $14.5 | 35% below |
| 100 week MA | $12.3 | 23% below |
| 200 week MA | $10.0 | 4.8% below |
COHN is in a downtrend: it's below all five of its weekly moving averages, and 4.8% below its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has the edge over COHN on trend strength, trading above more of its moving averages.
COHN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.82 | $16.5 | +331% |
| 2021 | $16.5 | $15.6 | -5.3% |
| 2022 | $15.6 | $8.79 | -44% |
| 2023 | $8.79 | $6.65 | -24% |
| 2024 | $6.65 | $10.4 | +56% |
| 2025 | $10.4 | $17.4 | +68% |
| 2026 YTD | $17.4 | $9.52 | -45% |
COHN has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.